Johnson & Johnson expects double-digit 2023 profit growth after Kenvue spinoff
J&J finalized the biggest shake-up in its 137-year history earlier this month through an exchange of its shares with Kenvue’s, leaving the pharmaceutical giant with a reduced 9.5% stake in its former unit